Antibacterial Agents TRIZ Cases

Sodium dichloroacetate and valproic acid salts modulate gene expression to treat viral and bacterial infections.

Galvanic particulates generate electric current through electrochemical reactions, replacing cumbersome patch devices to lower manufacturing costs.

Novel pyridinium bromide derivatives target Mycobacterium tuberculosis through specific structural modifications.

Modified alkyl phospholipid derivatives reduce cytotoxicity while maintaining efficacy against protozoal infections.

Fabs-in-tandem immunoglobulins bind two antigens by linking separate Fab fragments to Fc regions, simplifying production compared to quadroma methods.

A chimeric nucleic acid molecule uses non-AUG translation initiation sites to produce multiple antigenic peptides.

Structure-based design creates derivatives that inhibit ribosome function and overcome resistant bacterial strains.

Combining thymol with p-menthene alcohols achieves rapid disinfection within 15 seconds while minimizing corrosiveness and strong odors.

Specific fatty acid ratios reduce somatic cell counts and prevent clinical mastitis without gastrointestinal irritation.

Delmopinol-coated animal chews resolve the lack of specialized oral care products by inhibiting plaque, calculus, and halitosis in companion animals.

An alternatively spliced MD-2 polypeptide binds Toll-like receptor 4 to modulate immune signaling pathways.

Formula I compounds inhibit HPTP-beta enzyme activity to regulate angiogenesis, treating uncontrolled vessel growth in cancer and diabetic retinopathy.

N-(ortho phenylamino dihydropyridyl)sulfonamides inhibit MEK by matching the local binding pocket, resolving selectivity challenges against other kinases.

Stabilised polymeric silicate compositions prevent self-assembly into condensed forms, enabling efficient dissolution of resorbable silicates.

A PsaA-PspA fusion protein induces high-titre antibodies against Streptococcus pneumoniae.

An injectable fibrin sealant containing an anesthetic seals annulus fibrosus defects to reduce nucleus pulposus leakage and provide immediate pain relief.

Aluminum hydroxide, MPL, and WGP combination triggers TLR4 and Dectin-1 signaling to deliver durable protection against antibiotic-resistant infections.

Novel heterocyclocarboxamide derivatives provide potent fungicidal activity against phytopathogenic microorganisms.

A pH-sensitive indicator in the formulation changes color as solvents evaporate, resolving flammability risks and infection hazards from undried alcohol.

Pyridinium ionic liquid catalyzes imidazole formation, eliminating hazardous solvents while enhancing yield against drug-resistant microbes.

Pyrimido-diazepinone compounds inhibit PI3K-gamma and delta to resolve kinase selectivity issues.

Lactobacillus plantarum CMU995 overcomes low gastric acid tolerance and weak pathogen competition through enhanced epithelial adhesion.

Pyrazole-indole conjugates resolve the contradiction between photocytotoxicity and dark toxicity in photodynamic therapy.

Octenidine mouthwash formulation eliminates bitter taste and foaming while maintaining broad-spectrum antimicrobial activity against oral pathogens.

Encapsulating lysophosphatidylcholine in lipid nanomaterials resolves low solubility and hemolysis issues.

Extracellular vesicles deliver inhibitory nucleic acids to prokaryotic cells for targeted gene expression modulation.

Novel aryl nitrile compounds act as specific modulators of the CXCR3 chemokine receptor to address inflammatory disorders.

Aqueous oral care composition combines cationic steroidal ceragenins with quaternary ammonium compounds for enhanced antimicrobial activity.

Extracting dihydrostilbene derivatives from glycyrrhiza stems overcomes drug resistance in Helicobacter pylori treatments.

Statistical CDR definition and framework humanization reduce immunogenicity in camelid VHH antibodies without compromising toxin neutralizing activity.

Solvent-assisted extraction yields high-purity persimmon fiber that selectively inhibits pathogens while promoting beneficial microorganisms.

Serogroup X capsular polysaccharide conjugates stabilize in aqueous formulations through direct chemical coupling to carrier molecules.

Modifying fatty acid chains and polar head groups reduces NKT cell depletion, enabling sustained immune stimulation.

Oral multi-carotenoid composition reduces PSA levels and urinary symptoms in benign prostatic hyperplasia patients.

Novel compounds inhibit histone deacetylase 6 using zinc-binding groups and heteroaryl capping structures, resolving selectivity issues against HDAC1.

N-phosphonoxymethyl prodrugs of hydroxyalkyl thiadiazole derivatives deliver strong antibacterial activity against resistant Gram-positive strains.

CUCA motif oligoribonucleotides induce targeted IFN-alpha production while minimizing unwanted cytokine release.

2′-allene-substituted nucleoside derivatives inhibit viral replication while reducing toxicity compared to existing therapies.

Segmented synthetic GPL peptides eliminate false positives from related mycobacteria, enabling precise differential diagnosis of Map infections.

Cystobactamides overcome rapid bacterial resistance development by targeting specific penicillin-binding proteins with structural precision.

Rhamnogalacturonan I polysaccharides prevent Salmonellosis in animals without driving antimicrobial resistance, offering a reliable alternative to antibiotics.

Targeting the IL-33 receptor complex with specific agents resolves inadequate immune response modulation in inflammatory disorders.

Engineered scFv antibodies resolve the trade-off between therapeutic duration and administration flexibility by optimizing stability and solubility.

Combining inactivated B. hyodysenteriae from distinct gene clusters resolves the trade-off between strain-specific protection and broad cross-immunity.